Carolinas Wealth Consulting’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-41,356
Closed -$91K 414
2025
Q1
$91K Hold
41,356
0.02% 256
2024
Q4
$63.3K Buy
41,356
+13,669
+49% +$20.9K 0.01% 325
2024
Q3
$55.1K Buy
27,687
+5,857
+27% +$11.7K 0.01% 348
2024
Q2
$76.4K Buy
21,830
+2,130
+11% +$7.46K 0.01% 302
2024
Q1
$54.6K Buy
+19,700
New +$54.6K 0.01% 359